New Polling Results on the use of cost-effectiveness assessments


In November, 2021, Morning Consult ran a poll, conducted biannually, on behalf of Partnership to Improve Patient Care, focusing on the use of cost-effectiveness assessments to determine the value of coverage and treatment costs. As in previous years, the survey found that Americans want patients and their doctors in charge of health care decision making and are opposed to the use of cost assessments such as Quality-Adjusted Life Year (QALY). Today, PIPC Chairman Tony Coelho published an opinion…

Boston Globe: How health care systems do, and do not, support patients


Effective treatment for people with some chronic diseases and disabilities is being denied as policy makers and insurers, trying to lower drug costs, keep looking to easy and simplistic formulas that are overtly discriminatory to determine what the treatments are worth, and who is worth treating.